Apogee Therapeutics, Inc. (APGE)
NASDAQ·Healthcare·Biotechnology
$85.68
-0.91%
Mkt Cap $4.79B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 2, 2026 | — | — | — | -$1.05 | -$1.03 | +1.90% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$1.12 | -$1.11 | +0.89% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$1.03 | -$1.13 | -9.71% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$1.19 | -$0.95 | +20.17% | — | — |
| Q1 2025 Mar 3, 2025 | — | — | — | -$0.94 | -$1.19 | -26.60% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.88 | -$0.86 | +2.16% | — | — |
| Q3 2024 Aug 12, 2024 | — | — | — | -$0.64 | -$0.60 | +6.25% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$0.60 | -$0.64 | -6.67% | — | — |
| Q1 2024 Mar 5, 2024 | — | — | — | -$0.45 | -$0.32 | +28.89% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.38 | -$0.51 | -34.21% | — | — |
| Q3 2023 Jul 17, 2023 | — | — | — | -$1.70 | -$3.78 | -122.35% | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.25 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$0.28 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$0.39 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.04 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.08 | — | — | — |